The ectonucleotidases <scp>CD</scp>39 and <scp>CD</scp>73: Novel checkpoint inhibitor targets
2017 · Immunological Reviews · 849 citations
https://doi.org/10.1111/imr.12528
M
Maria Serena Longhi
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
251
Papers
7.9K
Citations
48
h-index
89
i10-index
Maria Serena Longhi is an academic researcher from Beth Israel Deaconess Medical Center. The author has contributed to research in topics: Liver Diseases and Immunity & Immune Cell Function and Interaction & Liver Disease Diagnosis and Treatment. The author has an h-index of 48, co-authored 214 publications.
ORCID: 0000-0002-4510-1249Papers by this author
worksAltered aryl-hydrocarbon-receptor signalling affects regulatory and effector cell immunity in autoimmune hepatitis
2020 · Journal of Hepatology · 59 citations
https://doi.org/10.1016/j.jhep.2020.06.044
HIF-1α-induced xenobiotic transporters promote Th17 responses in Crohn's disease
2018 · Journal of Autoimmunity · 51 citations
https://doi.org/10.1016/j.jaut.2018.07.022
Impact of Estrogen on Purinergic Signaling in Microvascular Disease
2025 · International Journal of Molecular Sciences · 4 citations
https://doi.org/10.3390/ijms26052105
Construction of a Chimeric Antibody with Therapeutic Potential for Cancers Which Overexpress c-erbB-2
1995 · Biochemical and Biophysical Research Communications · 2 citations
https://doi.org/10.1006/bbrc.1995.1882
Regulatory T-cells in autoimmune hepatitis: An historical perspective with hints to the future
2025 · JHEP Reports · 0 citations
https://doi.org/10.1016/j.jhepr.2025.101672
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat